(Q33614069)

28 July 2017

title

Pre-dosing antibody levels and efficacy of thrombolytic drugs containing streptokinase (English)

1 reference

28 July 2017

1 reference

1 reference

Gemmill JD

1

1 reference

28 July 2017

Hogg KJ

2

1 reference

28 July 2017

Dunn FG

3

1 reference

28 July 2017

Rae AP

4

1 reference

28 July 2017

Hillis WS

5

1 reference

28 July 2017

language of work or name

1 reference

1 September 1994

1 reference

28 July 2017

published in

British Heart Journal

1 reference

28 July 2017

volume

72

1 reference

28 July 2017

issue

3

1 reference

28 July 2017

page(s)

222-225

1 reference

Relationship of the lytic state to successful reperfusion with standard- and low-dose intracoronary streptokinase.

28 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1025505

Haloperidol decanoate. A preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in psychosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1025505

Clinical effects and kinetic properties of intravenous APSAC--anisoylated plasminogen-streptokinase activator complex (BRL 26921) in acute myocardial infarction

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1025505

Multicenter trial of intravenous anisoylated plasminogen streptokinase activator complex (APSAC) in acute myocardial infarction: effects on infarct size and left ventricular function

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1025505

Angiographic patency study of anistreplase versus streptokinase in acute myocardial infarction

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1025505

Antistreptokinase titres after intravenous streptokinase

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1025505

Streptokinase resistance: when might streptokinase administration be ineffective?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1025505

Monitoring of streptokinase resistance titre in acute myocardial infarction patients up to 30 months after giving streptokinase or anistreplase and related studies to measure specific antistreptokinase IgG

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1025505

Assessment of anti-streptokinase antibody levels in human sera using a microradioimmunoassay procedure.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1025505

Thrombolytic Therapy with Streptokinase Using a Standard Dosage Scheme

30 October 2018

1 reference

12 December 2020

[The effect of intravenously administered streptokinase on fibrinolysis and blood coagulation.]

1 reference

12 December 2020

Clinical failure of streptokinase due to an unsuspected high titer of antistreptokinase antibody

1 reference

12 December 2020

A randomized trial of intravenous and intracoronary streptokinase in patients with acute myocardial infarction

1 reference

12 December 2020

Acute myocardial infarction treated with intracoronary streptokinase: A report of the society for cardiac angiography

1 reference

12 December 2020

Identification of patients at risk for anaphylaxis due to streptokinase

1 reference

12 December 2020

Deacylation studies in vitro on anisoylated plasminogen streptokinase activator complex

1 reference

12 December 2020

Lack of influence of pretreatment antistreptokinase antibody on efficacy in a multicenter patency comparison of intravenous streptokinase and anistreplase in acute myocardial infarction

1 reference

12 December 2020

Raised levels of antistreptokinase antibody and neutralization titres from 4 days to 54 months after administration of streptokinase or anistreplase

1 reference

12 December 2020

Evaluation of a standard dosage schedule with streptokinase

1 reference

12 December 2020

Identifiers

DOI

10.1136/HRT.72.3.222

1 reference

28 July 2017

1 reference

28 July 2017

1 reference